Is Sugar Really the Biggest Risk to Your Health? A 30-Year Study Linked This Ingredient to More Heart Attacks and Strokes
A study of 17,710 people found that those with higher blood levels of a common sweetener were at increased risk of a major cardiovascular event.
A recent study has revealed that the Shingrix shingles vaccine may lower the risk of heart attack and stroke by 12% over the course of three-and-a-half years. Conducted by researchers at the University of Oxford, the study analyzed health records of 70,000 US adults aged 60 and above who received the vaccine. The findings, published in Nature Medicine, suggest that if confirmed by further clinical trials, the vaccine's cardiovascular benefits could be as significant as daily blood pressure-lowering medication.
Dr. Maxime Taquet, the study's lead author, stated that widespread vaccination against shingles could prevent hundreds of thousands of cardiovascular events worldwide, making it a highly impactful intervention for both brain and heart health in older adults. Shingles is a painful condition caused by the reactivation of the chickenpox virus, which can lead to nerve pain lasting months or years after the initial rash.
The Shingrix vaccine, which replaced the previous Zostavax in the US, has been shown to reduce the risk of shingles and its associated complications. While the absolute risk reduction is small, its potential impact on overall heart disease and stroke-related mortality could be substantial. Further clinical trials are being conducted to confirm the vaccine's cardiovascular effects, with researchers exploring potential mechanisms such as the vaccine's influence on the immune system and inflammation.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
